Literature DB >> 10737804

Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly.

K Murakami1, A Fellous, E E Baulieu, P Robel.   

Abstract

Fetal or adult rat-brain cytosol and fetal rat-brain microtubules contain a high-affinity, low-capacity pregnenolone-binding protein. The equilibrium dissociation constant is in the 30-50 nM range. The best competitors (in decreasing order) are pregnenolone sulfate, progesterone, Delta5-pregnene-3beta,20alpha-diol, and 3beta-hydroxy-5alpha-pregnan-20-one. It was hypothesized that the pregnenolone-binding protein pertained to microtubule-associated proteins (MAPs). Indeed, partial purification of fetal brain cytosol by fast pressure liquid chromatography with sequential ion-exchange and gel-filtration columns yielded two fractions, one of very high molecular mass, >200 kDa, and the other of 40-60 kDa, enriched in [(3)H]pregnenolone-binding activity and in proteins immunolabeled with monoclonal anti-tubulin and anti-MAP2 antibodies. Because many proteins are associated with microtubules, binding assays were repeated with purified calf-brain tubulin, MAP2, and Tau protein. Only the MAP2 fraction showed saturable [(3)H]pregnenolone binding with an affinity very close to that of rat-brain microtubules, but with a much larger concentration of binding sites (16 pmol/mg MAP2), which was increased more than 8-fold after copolymerization of MAP2 with tubulin. Finally, steroid effects on microtubule-assembly kinetics were assayed. Pregnenolone induced a large, dose-related increase of both the rate and extent of MAP2-induced tubulin assembly, whereas progesterone, inactive per se, counteracted the stimulatory effect of pregnenolone. Electron microscopic analysis confirmed that pregnenolone-increased assembly of microtubules produced a completely normal structure. The stimulatory effect on MAP2-tubulin interaction was also observed in fetal rat-brain neuron cultures. Therefore, we propose a mechanism of neurosteroid action, the control of microtubule or, more generally, of neural cytoskeleton dynamics, with potential roles in brain development, plasticity, and aging.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737804      PMCID: PMC16282          DOI: 10.1073/pnas.97.7.3579

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons.

Authors:  F Francis; A Koulakoff; D Boucher; P Chafey; B Schaar; M C Vinet; G Friocourt; N McDonnell; O Reiner; A Kahn; S K McConnell; Y Berwald-Netter; P Denoulet; J Chelly
Journal:  Neuron       Date:  1999-06       Impact factor: 17.173

2.  Phosphorylation states of microtubule-associated protein 2 (MAP2) determine the regulatory role of MAP2 in microtubule dynamics.

Authors:  T J Itoh; S Hisanaga; T Hosoi; T Kishimoto; H Hotani
Journal:  Biochemistry       Date:  1997-10-14       Impact factor: 3.162

Review 3.  Neurosteroids: of the nervous system, by the nervous system, for the nervous system.

Authors:  E E Baulieu
Journal:  Recent Prog Horm Res       Date:  1997

4.  Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development.

Authors:  N A Compagnone; S H Mellon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel.

Authors:  Y Fromes; P Gounon; R Veitia; M C Bissery; A Fellous
Journal:  J Protein Chem       Date:  1996-05

6.  Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers.

Authors:  E Hamel; C M Lin; E Flynn; R J D'Amato
Journal:  Biochemistry       Date:  1996-01-30       Impact factor: 3.162

7.  Mitogen-activated-protein-kinase-catalyzed phosphorylation of microtubule-associated proteins, microtubule-associated protein 2 and microtubule-associated protein 4, induces an alteration in their function.

Authors:  M Hoshi; K Ohta; Y Gotoh; A Mori; H Murofushi; H Sakai; E Nishida
Journal:  Eur J Biochem       Date:  1992-01-15

8.  Removal of the projection domain of microtubule-associated protein 2 alters its interaction with tubulin.

Authors:  A Fellous; V Prasad; R Ohayon; M A Jordan; R F Ludueña
Journal:  J Protein Chem       Date:  1994-05

9.  Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus.

Authors:  F P Monnet; V Mahé; P Robel; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Phosphorylation determines the binding of microtubule-associated protein 2 (MAP2) to microtubules in living cells.

Authors:  B Brugg; A Matus
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more
  30 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy.

Authors:  Laurence Meyer; Christine Patte-Mensah; Omar Taleb; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Life Sci       Date:  2010-04-30       Impact factor: 9.261

3.  3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders.

Authors:  Massimiliano Bianchi; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

4.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Authors:  Micah A Shelton; Jason T Newman; Hong Gu; Allan R Sampson; Kenneth N Fish; Matthew L MacDonald; Caitlin E Moyer; James V DiBitetto; Karl-Anton Dorph-Petersen; Peter Penzes; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

Review 5.  Structure-activity relationship studies on neuroactive steroids in memory, alcohol and stress-related functions: a crucial benefit from endogenous level analysis.

Authors:  Monique Vallée
Journal:  Psychopharmacology (Berl)       Date:  2014-04-30       Impact factor: 4.530

6.  Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor.

Authors:  Virginie Fontaine-Lenoir; Béatrice Chambraud; Arlette Fellous; Sébastien David; Yann Duchossoy; Etienne-Emile Baulieu; Paul Robel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

7.  Direct modulation of microtubule stability contributes to anthracene general anesthesia.

Authors:  Daniel J Emerson; Brian P Weiser; John Psonis; Zhengzheng Liao; Olena Taratula; Ashley Fiamengo; Xiaozhao Wang; Keizo Sugasawa; Amos B Smith; Roderic G Eckenhoff; Ivan J Dmochowski
Journal:  J Am Chem Soc       Date:  2013-03-29       Impact factor: 15.419

Review 8.  MAPREG: toward a novel approach of neuroprotection and treatment of Alzheimer's disease.

Authors:  Etienne-Emile Baulieu; Paul Robel; Arlette Fellous; Yann Duchossoy; Virginie Fontaine-Lenoir; Sebastien David
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins.

Authors:  Ioannis Charalampopoulos; Christos Tsatsanis; Erene Dermitzaki; Vasilia-Ismini Alexaki; Elias Castanas; Andrew N Margioris; Achille Gravanis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

10.  Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Authors:  Christine E Marx; Jimmy Lee; Mythily Subramaniam; Attilio Rapisarda; Dianne C T Bautista; Edwin Chan; Jason D Kilts; Robert W Buchanan; Eu Pui Wai; Swapna Verma; Kang Sim; Jayaraman Hariram; Rajesh Jacob; Richard S E Keefe; Siow Ann Chong
Journal:  Psychopharmacology (Berl)       Date:  2014-07-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.